From: Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
# | Diagnosis | Sex | Age of Onset (yr) | Age at Death (yr) | Disease Duration (yr) | Mutation Status | PMI (hr) | Brain weight (g) | ALS Stage | Braak stage | Thal phase | CERAD | LBD |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17 | ALS | M | 41 | 42 | 1 | – | 8 | 1554 | 2 | I/II | n/a | 0 | no |
18 | ALS | M | 71 | 76 | 5 | – | 23 | 1297 | 1 | I/II | n/a | A | no |
19 | ALS | M | 50 | 53 | 3 | – | 24 | 1422 | 2 | 0 | n/a | 0 | no |
20 | ALS-D | F | 50 | 51 | 1 | – | 4 | 1203 | 4 | I/II | n/a | 0 | no |
21 | ALS | M | 43 | 46 | 3 | – | 5 | 1427 | 3 | I/II | n/a | 0 | no |
22 | ALS | F | 79 | 81 | 2 | – | 10 | 1215 | 4 | III/IV | n/a | 0 | no |
23 | ALS | M | 64 | 66 | 2 | – | 14 | 1427 | 2 | I/II | n/a | 0 | no |
24 | ALS | M | 76 | 85 | 9 | – | 9 | 1041 | 1 | V/VI | n/a | C | diffuse neocortical |
25 | ALS | F | 73 | 75 | 2 | – | 8 | 1405 | 4 | I/II | n/a | A | no |
26 | ALS-D | F | 57 | 59 | 2 | – | 18 | 1125 | 4 | I/II | n/a | 0 | no |
27 | ALS/PLS | M | 54 | 74 | 20 | – | 4 | 1169 | 1 | I/II | n/a | 0 | no |
28 | ALS | M | 69 | 70 | 1 | – | 4 | 1135 | 1 | 0 | 0 | 0 | no |
29 | ALS | F | 63 | 67 | 4 | – | 10 | 1384 | 2 | 0 | 0 | 0 | no |
30 | ALS | F | 43 | 50 | 7 | – | n/a | 1237 | 2 | 0 | 0 | 0 | no |
31 | ALS | F | n/a | 48 | n/a | ATXN2 (22/32) | 5 | 1374 | 3 | 0 | n/a | 0 | no |
32 | ALS-D | M | n/a | 78 | n/a | ATXN2 (22/27) | 6 | 1300 | 4 | III/IV | n/a | B | transitional |
33 | ALS | F | 64 | 67 | 3 | ATXN2 (20/31) | 19 | 1229 | 3 | I/II | n/a | 0 | no |
34 | ALS | M | 63 | 65 | 2 | ATXN2 (22/29) | 7 | 1395 | 4 | III/IV | n/a | 0 | no |
35 | ALS | F | 54 | 56 | 2 | ATXN2 (22/27) | 10 | 1426 | 1 | I/II | n/a | 0 | no |
36 | ALS | M | 52 | 54 | 2 | C9orf72 | 4 | 1536 | 3 | 0 | n/a | 0 | no |
37 | FTD | F | 47 | 54 | 7 | C9orf72 | 12 | 813 | 4 | III/IV | n/a | 0 | no |
38 | ALS-D | M | 55 | 57 | 2 | C9orf72 | 9 | 1200 | 4 | III/IV | n/a | B | no |
39 | ALS-D | M | 54 | 57 | 3 | C9orf72 | 15 | 1244 | n/a | I/II | n/a | 0 | no |
40 | ALS-D | F | 67 | 69 | 2 | C9orf72 | 21 | 1079 | 4 | III/IV | n/a | B | no |
41 | ALS-D | M | 61 | 62 | 1 | C9orf72 | 30 | 1240 | 4 | I/II | n/a | 0 | no |
42 | ALS-D | M | 46 | 48 | 2 | C9orf72 | 13 | 1309 | 4 | I/II | n/a | 0 | no |
43 | ALS | M | 70 | 71 | 1 | C9orf72 | 18 | 1221 | 2 | V/VI | 2 | B | no |